Healthcare Industry News: Ventana
News Release - April 11, 2011
PLUS Diagnostics Names David Pauluzzi Chief Executive OfficerCompany Announces Promotion Following Third Year of Double-Digit Growth; Tim Brodnik to Continue as Executive Chairman
UNION, N.J., April 11, 2011 -- (Healthcare Sales & Marketing Network) -- PLUS Diagnostics, a leading anatomic pathology company, today announced the appointment of David Pauluzzi to chief executive officer. The company announced the promotion following its third consecutive year of double-digit growth. Mr. Pauluzzi, 49, has served as the company's president and chief operating officer since 2008. Tim Brodnik, a longtime laboratory industry veteran, will continue to work closely with Mr. Pauluzzi in his role as executive chairman.
"Dave has played an integral role in managing PLUS Diagnostics through a period of unprecedented growth. His focus on operational excellence, organic growth and customer service has enabled PLUS Diagnostics to successfully expand into new markets and services on a national level," said Brodnik. "I am confident that under Dave's leadership PLUS Diagnostics will continue to advance its diagnostic services to provide even greater value to our customers and their patients."
Mr. Pauluzzi has managed PLUS Diagnostics' expansion from a regional laboratory to a national anatomic pathology company. The company has made a series of investments in its services and technologies following its partnership with Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care. In the past three years, it has opened bi-coastal laboratories, extended its services to the gastroenterology and hematology/oncology specialties, and grown its customer base to increase net revenues more than 400 percent.
"It has been a privilege to work with Water Street and our management team to build PLUS Diagnostics into the leader it is today. I especially want to thank Tim Brodnik for his expertise and guidance," said Pauluzzi. "Together, we are focused on providing our customers with state-of-the-art science and technologies to support them with diagnosing and treating their patients as quickly as possible."
Prior to PLUS Diagnostics, Mr. Pauluzzi was a senior executive with Quest Diagnostics. He directed operations, marketing and sales for Quest's anatomic pathology and hospital businesses. Mr. Pauluzzi also held executive positions with US LABS and Ventana Medical Systems. He began his career with the diagnostics division of Abbott Laboratories.
About PLUS Diagnostics
PLUS Diagnostics is a leading national anatomic pathology company that provides a full range of multi-specialty services, including extensive diagnostic procedures and specialist consultations. Accredited by the College of American Pathologists, PLUS Diagnostics has long been recognized for exceptional service and quality. The company currently focuses on a broad base of specialty pathology services, including urology, gastroenterology and hematology/oncology. PLUS Diagnostics is a company of Water Street Healthcare Partners. For more information, visit, www.plusdx.com.
Source: PLUS Diagnostics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.